PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
65.08%
Revenue growth exceeding 1.5x VET's 1.60%. David Dodd would verify if faster growth reflects superior business model.
8.18%
Cost growth above 1.5x VET's 5.39%. Michael Burry would check for structural cost disadvantages.
113.05%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
29.06%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-32.71%
G&A reduction while VET shows 16.62% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-39.41%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-38.80%
Operating expenses reduction while VET shows 16.68% growth. Joel Greenblatt would examine advantage.
-21.83%
Total costs reduction while VET shows 12.02% growth. Joel Greenblatt would examine advantage.
-5.26%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-0.49%
D&A reduction while VET shows 74.84% growth. Joel Greenblatt would examine efficiency.
276.02%
EBITDA growth exceeding 1.5x VET's 14.60%. David Dodd would verify competitive advantages.
154.85%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
348.34%
Operating income growth while VET declines. John Neff would investigate advantages.
250.44%
Operating margin growth while VET declines. John Neff would investigate advantages.
9.09%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
257.60%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
195.47%
Pre-tax margin growth while VET declines. John Neff would investigate advantages.
1067.86%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
220.00%
Net income growth while VET declines. John Neff would investigate advantages.
172.69%
Net margin growth while VET declines. John Neff would investigate advantages.
219.88%
EPS growth while VET declines. John Neff would investigate advantages.
216.96%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-0.18%
Share count reduction while VET shows 3.44% change. Joel Greenblatt would examine strategy.
0.03%
Diluted share increase while VET reduces shares. John Neff would investigate differences.